Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Giant Cell Tumor of Bone

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Giant Cell Tumor of Bone

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 3 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null
      10 more-specific settings
      Oziltus: unresectable Giant Cell Tumor of Bone →XGEVA: unresectable Giant Cell Tumor of Bone →AUKELSO: unresectable Giant Cell Tumor of Bone →Denosumab-BMWO: unresectable Giant Cell Tumor of Bone →Bilprevda: unresectable Giant Cell Tumor of Bone →XTRENBO: unresectable Giant Cell Tumor of Bone →JUBEREQ: unresectable Giant Cell Tumor of Bone →WYOST: unresectable Giant Cell Tumor of Bone →Osenvelt: unresectable Giant Cell Tumor of Bone →BOMYNTRA: unresectable Giant Cell Tumor of Bone →

      Study evidence for this setting

      3 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00396279 · Source cited / selected · Scope: narrower

      Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00680992 · Source cited / selected · Scope: narrower

      Study of Denosumab in Subjects With Giant Cell Tumor of Bone

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03301857 · Source cited / selected · Scope: narrower

      Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-giant-cell-tumor-of-bone
        binding id
        ncit-C121932
        source collection
        ncit-concept
        source key
        C121932
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice